Unlocking the potential of PSMA as a cancer target
Interviewee/Contributor
Brian McGuinness and Theodora Harold
Organisation
Crescendo Biologics Ltd
Research Directory
New cancer drugs have unique mechanisms of action
Interviewee/ContributorBruno PagliaraOrganisationOncology specialist Bruno PagliaraLetter from Milano: The challenges facing biotech from the coronavirus
Interviewee/ContributorPierluigi ParacchiOrganisationGenenta Science SpAMechanism of immune disablement in HIV infection
Interviewee/ContributorJacques ThèzeOrganisationDiaccurate SASIndustry and public sector collaborate on recovery
Interviewee/ContributorVictoria EnglishOrganisationMedNousExploiting the measles vector platform for vaccines
Interviewee/ContributorErich TauberOrganisationThemis Bioscience GmbHConvalescent plasma hope in SARS-CoV-2 crisis
Interviewee/ContributorPeter CharlishOrganisationMedNousBiotechs fare relatively well amidst share collapse
Interviewee/ContributorWilliam EllingtonOrganisationMedNousCOVID-19's logistical impact on advanced therapies
Interviewee/ContributorMatthew LakelinOrganisationTrakCel LtdSolving the viral vector bottleneck during a pandemic
Interviewee/ContributorGéraldine Guérin-PeyrouOrganisationPolyplus-transfection SA